Lexington KY 肥胖症临床试验
10项针对 肥胖症的研究正在 Lexington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
招募中2 期
- AMR Clinical - Lexington, Lexington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- AMR Clinical, Lexington
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- The Research Group of Lexington LLC, Lexington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
招募中3 期
- The Alliance for Multispecialty Research LLC AMR, Lexington
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
招募中4 期欢迎健康志愿者
- University of Kentucky, Lexington
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- The Research Group of Lexington LLC, Lexington
Cannabis for Obesity Trial
招募中2 期欢迎健康志愿者
- University of Kentucky, Lexington
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
招募中观察性研究
- University of Kentucky, Lexington
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
招募中1 期
- MBX Biosciences Investigational Site, Lexington
2024 Tirzepatide-Bariatric Surgery
招募中4 期
- University of Kentucky, Lexington
其他城市的 肥胖症试验
- Houston, TX43 项研究
- Chicago, IL41 项研究
- New York City, NY40 项研究
- San Antonio, TX40 项研究
- Washington, DC33 项研究
- Orlando, FL31 项研究
- Dallas, TX30 项研究
- Boston, MA28 项研究
- Las Vegas, NV27 项研究
- Miami, FL27 项研究
- Baltimore, MD25 项研究
- Jacksonville, FL25 项研究
Lexington的其他研究
- 非小细胞肺癌23 项研究
- 肺癌18 项研究
- 卵巢癌16 项研究
- 癌症(所有类型)14 项研究
- 前列腺癌14 项研究
- 乳腺癌14 项研究
- 转移性癌症11 项研究
- 心力衰竭11 项研究
- 结直肠癌11 项研究
- 急性髓系白血病10 项研究
- 黑色素瘤10 项研究
- 胰腺癌9 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月5日。每项研究自行设定入选标准,由研究团队决定谁能参与。